RRC
45
-5
ADBE
62
-2
ADT
15
-5
AON
50
3
HAL
29
3
TSN
30
3
CHRW
42
5
VFC
38
-9
CAG
31
-2
LMT
37
-2
CI
46
-12
AES
51
-4
XRAY
22
11
PFG
37
3
COF
60
3
JPM
59
3
NWL
29
-3
PAYX
54
6
ABBV
68
2
NTRS
37
15
RRC
45
-5
ADBE
62
-2
ADT
15
-5
AON
50
3
HAL
29
3
TSN
30
3
CHRW
42
5
VFC
38
-9
CAG
31
-2
LMT
37
-2
CI
46
-12
AES
51
-4
XRAY
22
11
PFG
37
3
COF
60
3
JPM
59
3
NWL
29
-3
PAYX
54
6
ABBV
68
2
NTRS
37
15
Financhill
Back

abrdn Life Sciences Investors Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
54

HQL
abrdn Life Sciences Investors

Last Price:
13.80
Seasonality Move:
1.17%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Buy
54
abrdn Life Sciences Investors (HQL) is a Buy

Is abrdn Life Sciences Investors a Buy, Sell or Hold?

  • The current abrdn Life Sciences Investors [HQL] share price is $13.80. The Score for HQL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • HQL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HQL Stock Price Chart

What is abrdn Life Sciences Investors's stock price today?

  • The abrdn Life Sciences Investors share price today is $13.80
    The current trend is moderately bullish and HQL is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

HQL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 55.74 Buy
Chaikin Money Flow: -25351 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.4 - 14.06) Buy
Bollinger Bands (100): (13.24 - 13.96) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

HQL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.8 Sell
20-day SMA: 13.63 Buy
50-day SMA: 13.48 Buy
200-day SMA: 13.13 Buy
8-day EMA: 13.78 Buy
20-day EMA: 13.69 Buy
50-day EMA: 13.6 Buy
200-day EMA: 13.45 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

abrdn Life Sciences Investors Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):